Homo sapiens
gap_accession
phs003801
submitter handle
NCI_CALGB_40603
biospecimen repository
NCI_CALGB_40603
study name
Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer: DNA and RNA Sequencing
study design
Case Set
biospecimen repository sample id
Sample_PRE_RNA_302
submitted sample id
Sample_PRE_RNA_302
submitted subject id
Subject_302
gap_sample_id
3653100
gap_subject_id
3025433
sex
female
study disease
Breast Neoplasms
body site
breast
histological type
breast carcinoma
analyte type
RNA
is tumor
Yes
subject is affected
Yes
gap_consent_code
1
gap_consent_short_name
DS-CA